WIXOM, Mich. , Aug. 3, 2022
/PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI), a
commercial healthcare company focused on providing life-sustaining
products for patients suffering from blood disorders and diseases
associated with the kidney, today announced that it will release
its financial results for the second quarter ended June
30, 2022 on Monday, August 15, 2022. The Company will issue a
press release at 6:00am ET followed
by a live conference call and webcast at 8:00am ET.
CONFERENCE CALL AND WEBCAST DETAILS
Please call 10
minutes prior to the call to register.
Date: Monday, August 15, 2022
Time: 8:00am ET
Webcast: www.RockwellMed.com/Results
Live Number: (888) 660-6347 // (International) 1
(929) 201-6594
Replay Number: (800) 770-2030 // (International) 1 (647)
362-9199
Access Code: 4944610
Speakers: Mark Strobeck, Ph.D., President and Chief
Executive Officer; and Russell
Skibsted, Chief Financial Officer and Chief Business
Officer
Format: Discussion of second quarter 2022 operational
and financial results followed by Q&A.
A replay will be available via the replay number and webcast
through September 14, 2022.
About Rockwell Medical
Rockwell Medical is a
commercial healthcare company focused on providing life-sustaining
products for patients suffering from blood disorders and diseases
associated with the kidney. Rockwell is the second largest supplier
of acid and bicarbonate concentrates for dialysis patients in
the United States. The Company is
developing and commercializing a next-generation, proprietary
parenteral iron technology platform, Ferric Pyrophosphate Citrate
("FPC"), which has the potential to transform treatment options for
iron deficiency in multiple disease states, reduce healthcare costs
and improve patients' lives. Rockwell has two FDA-approved
therapies indicated for patients undergoing hemodialysis, which are
the first two products developed from the FPC platform. Rockwell is
also advancing its FPC platform by developing FPC for the treatment
of iron deficiency anemia in patients outside of dialysis, who are
receiving medications in the home infusion setting. For more
information, visit www.RockwellMed.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/rockwell-medical-to-release-second-quarter-2022-financial-results-on-monday-august-15-301598614.html
SOURCE Rockwell Medical, Inc.